MassGeneral Magazine’s August issue profiles the creation of Cure Alzheimers Fund and highlights the success of our venture capital approach. The article details the innovative work being done by Dr. Tanzi, such as the Alzheimer’s Genome Project, thanks to the bold investments of Cure Alzheimer’s.

In the years when the Alzheimer’s scientific community was focused on better understanding and exploiting the four known genes implicated in the disease, Dr. Tanzi was one of few researchers advocating for finding others. By design, CAF’s founders — who had spent their careers in venture capital, banking and real estate — had established that the organization would do away with the red tape and reams of paperwork required for most grant proposals. And that modus operandi has resonated with the thousands of other donors who give to CAF.

To read the rest of the article, click here.

For a more in-depth look at the Alzheimer’s Genome Project, read MassGeneral Magazine’s article, “Unforgettable Breakthroughs in Alzheimer’s,” in the same issue.